Cutaneous Lupus Erythematosus Clinical Trials

A listing of Cutaneous Lupus Erythematosus medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

Research Center
Anniston Alabama 36207

LILAC Study – For Patients with Cutaneous and/or Systemic Lupus

View More ▼

Anniston Alabama 36207

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)

Arizona

Phoenix Arizona 85032

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)

California

Research Center
La Mesa California 91942

LILAC Study – For Patients with Cutaneous and/or Systemic Lupus

Research Center
Los Angeles California 90045

LILAC Study – For Patients with Cutaneous and/or Systemic Lupus

Research Center
Tustin California 92780

LILAC Study – For Patients with Cutaneous and/or Systemic Lupus

Research Center
Upland California 91786

LILAC Study – For Patients with Cutaneous and/or Systemic Lupus

Research Center
Upland California 91786

LILAC Study – For Patients with Cutaneous and/or Systemic Lupus

Research Center
West Hills California 91307

LILAC Study – For Patients with Cutaneous and/or Systemic Lupus

View More ▼

Los Angeles California 90045

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)

San Diego California 92120

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)

Tustin California 92780

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)

Upland California 91786

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)

West Hills California 91307

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)

West Hollywood California 90048

Patients are needed to participate in a clinical research study of Milatuzumab

Florida

Orlando Florida 32806

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)

Georgia

Research Center
Sandy Springs Georgia 30328

LILAC Study – For Patients with Cutaneous and/or Systemic Lupus

View More ▼

Atlanta Georgia 30342

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)

Indiana

Research Center
Indianapolis Indiana 46256

LILAC Study – For Patients with Cutaneous and/or Systemic Lupus

View More ▼

Indianapolis Indiana 46256

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)

Massachusetts

Research Center
Boston Massachusetts 02115

LILAC Study – For Patients with Cutaneous and/or Systemic Lupus

Michigan

Research Center
Ann Arbor Michigan 48109

LILAC Study – For Patients with Cutaneous and/or Systemic Lupus

Missouri

Research Center
St. Louis Missouri 63110

LILAC Study – For Patients with Cutaneous and/or Systemic Lupus

View More ▼

St. Louis Missouri 63110

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)

Nevada

Research Center
Las Vegas Nevada 89128

LILAC Study – For Patients with Cutaneous and/or Systemic Lupus

New Jersey

Summit New Jersey 07901

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)

New York

Research Center
Great Neck New York 11021

LILAC Study – For Patients with Cutaneous and/or Systemic Lupus

View More ▼

Great Neck New York 11020

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)

North Carolina

Research Center
Charlotte North Carolina 28204

LILAC Study – For Patients with Cutaneous and/or Systemic Lupus

Research Center
Charlotte North Carolina 28207

LILAC Study – For Patients with Cutaneous and/or Systemic Lupus

Research Center
Wilmington North Carolina 28401

LILAC Study – For Patients with Cutaneous and/or Systemic Lupus

View More ▼

Charlotte North Carolina 28207

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)

Charlotte North Carolina 28204

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)

Greensboro North Carolina 27408

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)

Wilmington North Carolina 28401

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)

Ohio

Columbus Ohio 43230

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)

Pennsylvania

Research Center
Pittsburgh Pennsylvania 15213

LILAC Study – For Patients with Cutaneous and/or Systemic Lupus

View More ▼

Duncansville Pennsylvania 16635

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)

Pittsburgh Pennsylvania 15213

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)

Texas

Research Center
Austin Texas 78731

LILAC Study – For Patients with Cutaneous and/or Systemic Lupus

Research Center
Austin Texas 78731

LILAC Study – For Patients with Cutaneous and/or Systemic Lupus

View More ▼

Austin Texas 78731

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)

Virginia

Research Center
Norfolk Virginia 23502

LILAC Study – For Patients with Cutaneous and/or Systemic Lupus

View More ▼

Norfolk Virginia 23507

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)

Germany

Berlin 10117

A clinical trial to evaluate treatments using GSK2646264 1% and Placebo for patients with Lupus Erythematosus, Cutaneous

Leipzig Saxony 04103

A clinical study for patients with Lupus Erythematosus, Cutaneous or Lupus Erythematosus, Discoid

Korea, Republic of

Suwon-si Gyeonggi-do 16499

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)

United Kingdom

Leeds LS7 4SA

A clinical trial seeking patients for a research study for the treatment of Lupus Erythematosus, Discoid, Lupus Erythematosus, Cutaneous or Lupus Erythematosus, Chronic Cutaneous